Total Payments
$2,808
2024 Payments
$21.23
Companies
22
Transactions
262
Medicare Patients
1,749
Medicare Billing
$155,311
Payment Breakdown by Category
Food & Beverage$2,808 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,808 | 262 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $777.88 | 90 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $481.32 | 25 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $400.24 | 43 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $235.77 | 19 | $0 (2020) |
| PFIZER INC. | $230.91 | 36 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $122.56 | 8 | $0 (2019) |
| Lilly USA, LLC | $100.28 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $89.47 | 7 | $0 (2019) |
| Amgen Inc. | $48.86 | 3 | $0 (2019) |
| Abbott Laboratories | $47.00 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.23 | 1 | ABBVIE INC. ($21.23) |
| 2023 | $46.73 | 3 | Novo Nordisk Inc ($31.34) |
| 2022 | $12.42 | 1 | Novo Nordisk Inc ($12.42) |
| 2021 | $98.42 | 7 | Novo Nordisk Inc ($67.41) |
| 2020 | $342.20 | 32 | PFIZER INC. ($119.09) |
| 2019 | $879.47 | 91 | Novo Nordisk Inc ($218.47) |
| 2018 | $691.17 | 60 | AstraZeneca Pharmaceuticals LP ($205.81) |
| 2017 | $716.39 | 67 | Merck Sharp & Dohme Corporation ($209.63) |
All Payment Transactions
262 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Obesity | ||||||
| 03/24/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Obesity | ||||||
| 01/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 04/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Diabetes | ||||||
| 12/10/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes Care | ||||||
| 08/13/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Diabetes | ||||||
| 05/13/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Obesity | ||||||
| 05/05/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Diabetes | ||||||
| 04/30/2021 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Endocrinology | ||||||
| 03/27/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Obesity | ||||||
| 02/10/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Obesity | ||||||
| 11/04/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: GASTROINTESTINAL | ||||||
| 10/29/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Obesity | ||||||
| 10/13/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: Obesity | ||||||
| 09/28/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, STEGLATRO | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/18/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: Obesity | ||||||
| 09/10/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Obesity | ||||||
| 08/06/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/17/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Obesity | ||||||
| 06/09/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Obesity | ||||||
| 06/01/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/25/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: GASTROINTESTINAL | ||||||
| 05/04/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 03/25/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 312 | 540 | $98,956 | $29,793 |
| 2022 | 6 | 492 | 843 | $125,565 | $40,044 |
| 2021 | 7 | 473 | 866 | $134,781 | $34,773 |
| 2020 | 9 | 472 | 878 | $125,563 | $50,701 |
Total Patients
1,749
Total Services
3,127
Medicare Billing
$155,311
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 160 | 334 | $72,606 | $20,878 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 142 | $18,034 | $6,194 | 34.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $8,316 | $2,721 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 414 | $72,036 | $17,488 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 230 | $26,910 | $9,231 | 34.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 122 | 122 | $9,516 | $5,965 | 62.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 34 | 34 | $7,480 | $3,877 | 51.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $3,015 | $2,173 | 72.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 28 | $6,608 | $1,310 | 19.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 174 | 445 | $77,430 | $17,339 | 22.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 123 | 238 | $27,846 | $9,136 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 80 | 80 | $8,940 | $3,434 | 38.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 41 | 41 | $9,020 | $1,931 | 21.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 22 | $5,192 | $1,251 | 24.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 24 | 29 | $2,987 | $1,034 | 34.6% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 11 | 11 | $3,366 | $647.54 | 19.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 187 | 407 | $70,818 | $27,391 | 38.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 114 | 231 | $27,027 | $11,191 | 41.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 42 | 55 | $12,980 | $4,568 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 22 | 22 | $4,092 | $2,463 | 60.2% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 31 | 58 | $3,364 | $1,779 | 52.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 29 | 33 | $2,640 | $1,774 | 67.2% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 17 | 29 | $2,987 | $1,192 | 39.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 17 | 27 | $1,431 | $250.02 | 17.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2020 | 13 | 16 | $224.00 | $92.01 | 41.1% |
About Dr. John Sawvel, DO
Dr. John Sawvel, DO is a Family Medicine healthcare provider based in Beavercreek, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780682146.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Sawvel, DO has received a total of $2,808 in payments from pharmaceutical and medical device companies, with $21.23 received in 2024. These payments were reported across 262 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,808).
As a Medicare-enrolled provider, Sawvel has provided services to 1,749 Medicare beneficiaries, totaling 3,127 services with total Medicare billing of $155,311. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Neuromusculoskeletal Medicine & OMM
- Location Beavercreek, OH
- Active Since 07/11/2005
- Last Updated 05/30/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780682146
Products in Payments
- FARXIGA (Drug) $378.48
- JANUVIA (Drug) $304.17
- Ozempic (Drug) $281.10
- Saxenda (Drug) $278.77
- COLOGUARD (Device) $140.24
- TRADJENTA (Drug) $128.64
- Victoza (Drug) $113.52
- TOUJEO (Drug) $107.94
- JARDIANCE (Drug) $82.60
- CHANTIX (Drug) $76.68
- ASMANEX (Drug) $61.54
- SYMBICORT (Drug) $56.39
- TRULICITY (Drug) $41.93
- MYRBETRIQ (Drug) $39.15
- Tresiba (Drug) $36.66
- BEVESPI AEROSPHERE (Drug) $35.65
- Aimovig (Biological) $34.12
- SPIRIVA RESPIMAT (Drug) $32.05
- Wegovy (Drug) $31.34
- VIBERZI (Drug) $29.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Beavercreek
Kevin Carter, Do, DO
Family Medicine — Payments: $53,015
Family Medicine $53,015
Dr. Daniel Whitmer, M.d, M.D
Family Medicine — Payments: $4,371
Family Medicine $4,371
Dr. Rebecca Cherry, Md, MD
Family Medicine — Payments: $4,092
Family Medicine $4,092
Luis Tellez, Md, MD
Family Medicine — Payments: $1,460
Family Medicine $1,460
Mark Ringle, Md, MD
Family Medicine — Payments: $1,369
Family Medicine $1,369
Mrs. Carrie Evans, Cnp, CNP
Family Medicine — Payments: $1,082
Family Medicine $1,082